<p>Guggenheim 分析师 Seamus Fernandez 今天重申了对 Amylyx Pharmaceuticals Inc 的买入评级，并设定了 30.00 美元的目标价。</p>
<h3>在 TipRanks 上享受 55% 的折扣</h3>
<ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>发现表现优异的股票投资理念，并升级到市场领先者的投资组合，使用智能投资者精选</li>
</ul>
<p>Fernandez 关注医疗保健行业，重点关注 MBX Biosciences, Inc.、Rhythm Pharmaceuticals 和 Bristol-Myers Squibb 等股票。根据 TipRanks，Fernandez 推荐股票的平均回报率为 25.0%，成功率为 61.33%。</p>
<p>在 5 月 9 日发布的报告中，LifeSci Capital 也对该股票给予了买入评级，目标价为 24.00 美元。</p>

AMLX

<p>Guggenheim 分析师 Seamus Fernandez 重申了对 Amylyx Pharmaceuticals Inc (AMLX) 的买入评级，目标价为 30.00 美元。Fernandez 专注于医疗保健行业，其股票推荐的平均回报率为 25.0%，成功率为 61.33%。此外，LifeSci Capital 也在 5 月 9 日发布的报告中对 AMLX 给予了买入评级，目标价为 24.00 美元</p>

<p>Guggenheim analyst Seamus Fernandez reiterated a Buy rating on Amylyx Pharmaceuticals Inc today and set a price target of $30.00.</p>
<div class="lb-trans"><p>Guggenheim 分析师 Seamus Fernandez 今天重申了对 Amylyx Pharmaceuticals Inc 的买入评级，并设定了 30.00 美元的目标价。</p>
</div><h3>Claim 55% Off TipRanks</h3>
<div class="lb-trans"><h3>在 TipRanks 上享受 55% 的折扣</h3>
</div><ul>
<li>Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions</li>
<li>Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>发现表现优异的股票投资理念，并升级到市场领先者的投资组合，使用智能投资者精选</li>
</ul>
</div><p>Fernandez covers the Healthcare sector, focusing on stocks such as MBX Biosciences, Inc., Rhythm Pharmaceuticals, and Bristol-Myers Squibb. According to TipRanks, Fernandez has an average return of 25.0% and a 61.33% success rate on recommended stocks.</p>
<div class="lb-trans"><p>Fernandez 关注医疗保健行业，重点关注 MBX Biosciences, Inc.、Rhythm Pharmaceuticals 和 Bristol-Myers Squibb 等股票。根据 TipRanks，Fernandez 推荐股票的平均回报率为 25.0%，成功率为 61.33%。</p>
</div><p>In a report released on May 9, LifeSci Capital also assigned a Buy rating to the stock with a $24.00 price target.</p>
<div class="lb-trans"><p>在 5 月 9 日发布的报告中，LifeSci Capital 也对该股票给予了买入评级，目标价为 24.00 美元。</p>
</div>

Amylyx Pharmaceuticals Inc (AMLX) 获得了古根海姆的买入评级